This invention provides for a chewable veterinary formulation, which does not contain animal products, which comprises: effective amount of a pharmaceutically active agent which comprises either: a) at least one nodulisporamide acid or nodulisporic acid derivative； or b) a combination comprising i) at least one avermectin or milbemycin derivative； and ii) at least one compound selected from the group consisting of praziquantel and pyrantel； at least one binder； at least one disintegrant； at least one non-animal product containing flavor or flavor derived from a non-animal source； at least one binder； at least one humectant； at least one granulating solvent； and optionally, at least one antioxidant, at least one buffering agent, at least one preservative, or at least one colorant.
